Back to top

Bellicum Pharmaceuticals (BLCM) in Focus: Stock Moves 13.8% Higher
August 29, 2017

Read MoreHide Full Article

Bellicum Pharmaceuticals, Inc.(BLCM - Free Report) was a big mover last session, as the company saw its shares rise nearly 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $7.52-$10.88 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen four negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Bellicum Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked stock in the retail sector is Ipsen S.A. (IPSEY - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is BLCM going up? Or down? Predict to see what others think: Up or Down

Zacks' 10-Minute Stock-Picking Secret

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

But here's something even more remarkable: You can master this proven system without going to a single class or seminar. And then you can apply it to your portfolio in as little as 10 minutes a month.

Learn the secret >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Bellicum Pharmaceuticals, Inc. (BLCM) - free report >>

IPSEN SA ADR (IPSEY) - free report >>


More from Zacks Tale of the Tape

You May Like